Overview

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if certain drugs commonly used to treat multiple sclerosis have an effect on bone health.
Details
Lead Sponsor:
Nancy Hammond, MD
Collaborator:
Kansas City Area Life Sciences Institute, Inc.
Treatments:
(T,G)-A-L
Glatiramer Acetate
Interferon beta-1a
Interferon beta-1b
Interferon-beta
Interferons